Stockreport

Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting

Ocuphire Pharma, Inc.  (OCUP) 
PDF FARMINGTON HILLS, Mich., April 22, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP) (“Ocuphire”), a clinical-stage biopharmaceutical company focused on de [Read more]